Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia

被引:60
作者
Jones, RN [1 ]
机构
[1] Univ Iowa, Coll Med, Dept Pathol, Div Med Microbiol, Iowa City, IA 52242 USA
关键词
D O I
10.1086/598621
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
One of the most challenging problems in antimicrobial chemotherapy is the effective empirical treatment of infection in patients with neutropenia. The rates of occurrence for pathogens have significantly changed (from predominance of gram-negative to gram-positive organisms) under selective pressure of broad-spectrum antimicrobial therapy or prophylaxis, and novel resistance mechanisms have emerged. To address the need for appropriate monotherapy or combination regimens for patients with neutropenia, physicians must prescribe agents with a spectrum of antimicrobial activity to inhibit the major, prevalent pathogens encountered in bloodstream infection and pneumonia; in addition, these selected agents must be active against recently described resistant organisms. Data from the SENTRY Antimicrobial Surveillance Program indicate that several broad-spectrum agents remain highly active and can be used alone or in combinations. In most cases, the newer compounds with increased activity and spectrum against gram-positive cocci (i.e., carbapenems, cefepime, levofloxacin, and trovafloxacin) offer a greater inhibitory potential for empirical therapy among patients with neutropenia and severe infections.
引用
收藏
页码:495 / 502
页数:8
相关论文
共 47 条
[1]  
*AM SOC MICR, 1995, ANTIMICROB AGENTS S, V6, P1
[2]  
*AM THOR SOC, 1995, AM J RESP CRIT CARE, V153, P1711
[3]   CEFEPIME - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE [J].
BARRADELL, LB ;
BRYSON, HM .
DRUGS, 1994, 47 (03) :471-505
[4]   RECOVERY OF UNCOMMON BACTERIA FROM BLOOD - ASSOCIATION WITH NEOPLASTIC DISEASE [J].
BEEBE, JL ;
KONEMAN, EW .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (03) :336-356
[5]   BACTEREMIA DUE TO VIRIDANS STREPTOCOCCI IN NEUTROPENIC PATIENTS - A REVIEW [J].
BOCHUD, PY ;
CALANDRA, T ;
FRANCIOLI, P .
AMERICAN JOURNAL OF MEDICINE, 1994, 97 (03) :256-264
[6]  
Bryskier A., 1994, EXPERT OPIN INV DRUG, V3, P145, DOI [10.1517/13543784.3.2.145, DOI 10.1517/13543784.3.2.145]
[7]   CEFTAZIDIME RESISTANCE AMONG SELECTED NOSOCOMIAL GRAM-NEGATIVE BACILLI IN THE UNITED-STATES [J].
BURWEN, DR ;
BANERJEE, SN ;
GAYNES, RP .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06) :1622-1625
[8]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[9]   Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: A comparative study [J].
Cordonnier, C ;
Herbrecht, R ;
Pico, JL ;
Gardembas, M ;
Delmer, A ;
Delain, M ;
Moreau, P ;
Ladeb, S ;
Nalet, V ;
Rollin, C ;
Gres, JJ .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (01) :41-51
[10]   Emerging resistance to antimicrobial agents in gram-positive bacteria - Enterococci, staphylococci and nonpneumococcal streptococci [J].
Cormican, MG ;
Jones, RN .
DRUGS, 1996, 51 :6-12